WDB coco Co., Ltd. provides contract services to pharmaceutical companies in Japan. The company supports the development of pharmaceuticals and medical devices with a focus on safety information management; safety information management support; clinical development support/monitoring; and post-marketing surveillance facility contract support related work services. It also provides contract support for the preparation of various documents, translation, and QC; temporary staffing; and document-related work in development, approval application, manufacturing, etc. In addition, the company offers one-stop CRO services for general new drug development, such as monitoring work, safety information-related work, data management, and statistical analysis. WDB coco Co., Ltd. was incorporated in 1984 and is headquartered in Tokyo, Japan.
Stock data | 2023 | Change |
---|---|---|
Price | $27.48 | N/A |
Market Cap | $65.66M | N/A |
Shares Outstanding | 2.39M | 1.05% |
Employees | 471.00 | N/A |
Shareholder Equity | 2.80B | 30.48% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.09 | N/A |
P/S Ratio | 2.29 | N/A |
P/B Ratio | 0.02 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0019 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $28.65M | N/A |
Earnings | $5.23M | N/A |
EPS | 309.31 | N/A |
Earnings Yield | 11.26 | N/A |
Gross Margin | 0.3904 | N/A |
Operating Margin | 0.2667 | N/A |
Net income margin | 0.1827 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $25.76M | N/A |
Total Debt | $171.15K | N/A |
Cash on Hand | $14.09M | N/A |
Debt to Equity | 0.0022 | -33.27% |
Cash to Debt | $82.31 | 46.10% |
Current Ratio | $4.24 | 31.41% |